dc.creatorColque, Claudia Antonella
dc.creatorAlbarracín Orio, Andrea Georgina
dc.creatorFeliziani, S.
dc.creatorMarvig, R. L.
dc.creatorTobares, Romina Alín
dc.creatorJohansen, H.K.
dc.creatorMolin, S.
dc.creatorSmania, Andrea
dc.date.accessioned2021-03-26T21:11:56Z
dc.date.accessioned2022-10-15T05:05:49Z
dc.date.available2021-03-26T21:11:56Z
dc.date.available2022-10-15T05:05:49Z
dc.date.created2021-03-26T21:11:56Z
dc.date.issued2019-10
dc.identifierColque, Claudia Antonella; Albarracín Orio, Andrea Georgina; Feliziani, S.; Marvig, R. L.; Tobares, Romina Alín; et al.; Hypermutator pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients; American Society for Microbiology; Antimicrobial Agents and Chemotherapy; 64; 5; 10-2019; 1-38
dc.identifier0066-4804
dc.identifierhttp://hdl.handle.net/11336/129077
dc.identifier1098-6596
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4347982
dc.description.abstractPseudomonas aeruginosa exploits intrinsic and acquired resistance mechanisms to resist almost every antibiotic used in chemotherapy. Antimicrobial resistance in P. aeruginosa isolates recovered from cystic fibrosis (CF) patients is further enhanced by the occurrence of hypermutator strains, a hallmark of chronic infections in CF patients. However, the within-patient genetic diversity of P. aeruginosa populations related to antibiotic resistance remains unexplored. Here, we show the evolution of the mutational resistome profile of a P. aeruginosa hypermutator lineage by performing longitudinal and transversal analyses of isolates collected from a CF patient throughout 20 years of chronic infection. Our results show the accumulation of thousands of mutations, with an overall evolutionary history characterized by purifying selection. However, mutations in antibiotic resistance genes appear to have been positively selected, driven by antibiotic treatment. Antibiotic resistance increased as infection progressed toward the establishment of a population constituted by genotypically diversified coexisting sublineages, all of which converged to multidrug resistance. These sublineages emerged by parallel evolution through distinct evolutionary pathways, which affected genes of the same functional categories. Interestingly, ampC and ftsI, encoding the β-lactamase and penicillin-binding protein 3, respectively, were found to be among the most frequently mutated genes. In fact, both genes were targeted by multiple independent mutational events, which led to a wide diversity of coexisting alleles underlying β-lactam resistance. Our findings indicate that hypermutators, apart from boosting antibiotic resistance evolution by simultaneously targeting several genes, favor the emergence of adaptive innovative alleles by clustering beneficial/compensatory mutations in the same gene, hence expanding P. aeruginosa strategies for persistence.
dc.languageeng
dc.publisherAmerican Society for Microbiology
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://pubmed.ncbi.nlm.nih.gov/32071060/
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1128/aac.02142-19
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAMPC
dc.subjectCYSTIC FIBROSIS
dc.subjectFTSI
dc.subjectHYPERMUTABILITY
dc.subjectMULTIDRUG RESISTANCE
dc.subjectPSEUDOMONAS AERUGINOSA
dc.titleHypermutator pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución